ID   SET1B_HUMAN             Reviewed;        1966 AA.
AC   Q9UPS6; F6MFW1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   19-MAR-2014, sequence version 3.
DT   10-MAY-2017, entry version 126.
DE   RecName: Full=Histone-lysine N-methyltransferase SETD1B;
DE            EC=2.1.1.43;
DE   AltName: Full=Lysine N-methyltransferase 2G;
DE   AltName: Full=SET domain-containing protein 1B;
DE            Short=hSET1B;
GN   Name=SETD1B; Synonyms=KIAA1076, KMT2G, SET1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RBM15, AND
RP   MUTAGENESIS OF LEU-577 AND ASP-579.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4
RT   methyltransferase via a SPOC domain that is required for cytokine-
RT   independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1163-1966 (ISOFORM 1/2).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   ENZYME ACTIVITY, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE SET1
RP   COMPLEX.
RX   PubMed=17355966; DOI=10.1074/jbc.M609809200;
RA   Lee J.-H., Tate C.M., You J.-S., Skalnik D.G.;
RT   "Identification and characterization of the human Set1B histone H3-
RT   Lys4 methyltransferase complex.";
RL   J. Biol. Chem. 282:13419-13428(2007).
RN   [5]
RP   IDENTIFICATION IN SET1 COMPLEX, AND INTERACTION WITH WDR82; ASH2L AND
RP   POLR2A.
RX   PubMed=17998332; DOI=10.1128/MCB.01356-07;
RA   Lee J.H., Skalnik D.G.;
RT   "Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A
RT   Histone H3-Lys4 methyltransferase complex to transcription start sites
RT   of transcribed human genes.";
RL   Mol. Cell. Biol. 28:609-618(2008).
RN   [6]
RP   IDENTIFICATION IN SET1 COMPLEX.
RX   PubMed=18838538; DOI=10.1128/MCB.00976-08;
RA   Wu M., Wang P.F., Lee J.S., Martin-Brown S., Florens L., Washburn M.,
RA   Shilatifard A.;
RT   "Molecular regulation of H3K4 trimethylation by Wdr82, a component of
RT   human Set1/COMPASS.";
RL   Mol. Cell. Biol. 28:7337-7344(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1659, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-986; SER-994 AND
RP   SER-1031, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1335, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Histone methyltransferase that specifically methylates
CC       'Lys-4' of histone H3, when part of the SET1 histone
CC       methyltransferase (HMT) complex, but not if the neighboring 'Lys-
CC       9' residue is already methylated. H3 'Lys-4' methylation
CC       represents a specific tag for epigenetic transcriptional
CC       activation. The non-overlapping localization with SETD1A suggests
CC       that SETD1A and SETD1B make non-redundant contributions to the
CC       epigenetic control of chromatin structure and gene expression.
CC       Specifically tri-methylates 'Lys-4' of histone H3 in vitro.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] =
CC       S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone].
CC       {ECO:0000269|PubMed:17355966}.
CC   -!- SUBUNIT: Component of the SET1 complex, at least composed of the
CC       catalytic subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5,
CC       ASH2L/ASH2, CXXC1/CFP1, HCFC1 and DPY30. Interacts with HCFC1 and
CC       ASH2L/ASH2. Interacts (via the RRM domain) with WDR82. Interacts
CC       (via the RRM domain) with hyperphosphorylated C-terminal domain
CC       (CTD) of RNA polymerase II large subunit (POLR2A) only in the
CC       presence of WDR82. Binds specifically to CTD heptad repeats
CC       phosphorylated on 'Ser-5' of each heptad. Interacts with RBM15.
CC       {ECO:0000269|PubMed:17355966, ECO:0000269|PubMed:17998332,
CC       ECO:0000269|PubMed:18838538, ECO:0000269|PubMed:22927943}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:17355966}. Chromosome
CC       {ECO:0000269|PubMed:17355966}. Note=Localizes to a largely non-
CC       overlapping set of euchromatic nuclear speckles with SETD1A,
CC       suggesting that SETD1A and SET1B each bind to a unique set of
CC       target genes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPS6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPS6-2; Sequence=VSP_053875, VSP_053876;
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding
CC       methyltransferase superfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00190}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JF813787; AEG67286.1; -; mRNA.
DR   EMBL; AC079360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB028999; BAA83028.1; -; mRNA.
DR   CCDS; CCDS53838.1; -. [Q9UPS6-2]
DR   RefSeq; NP_055863.1; NM_015048.1. [Q9UPS6-2]
DR   RefSeq; XP_005253915.1; XM_005253858.4. [Q9UPS6-1]
DR   RefSeq; XP_006719359.1; XM_006719296.3. [Q9UPS6-1]
DR   UniGene; Hs.507122; -.
DR   PDB; 3UVO; X-ray; 2.20 A; B=1745-1755.
DR   PDB; 4ES0; X-ray; 1.82 A; C=1741-1754.
DR   PDBsum; 3UVO; -.
DR   PDBsum; 4ES0; -.
DR   ProteinModelPortal; Q9UPS6; -.
DR   SMR; Q9UPS6; -.
DR   BioGrid; 116702; 22.
DR   DIP; DIP-61947N; -.
DR   IntAct; Q9UPS6; 13.
DR   STRING; 9606.ENSP00000267197; -.
DR   iPTMnet; Q9UPS6; -.
DR   PhosphoSitePlus; Q9UPS6; -.
DR   BioMuta; SETD1B; -.
DR   DMDM; 166977692; -.
DR   EPD; Q9UPS6; -.
DR   PaxDb; Q9UPS6; -.
DR   PeptideAtlas; Q9UPS6; -.
DR   PRIDE; Q9UPS6; -.
DR   Ensembl; ENST00000542440; ENSP00000442924; ENSG00000139718. [Q9UPS6-2]
DR   Ensembl; ENST00000604567; ENSP00000474253; ENSG00000139718. [Q9UPS6-1]
DR   Ensembl; ENST00000619791; ENSP00000481531; ENSG00000139718. [Q9UPS6-1]
DR   GeneID; 23067; -.
DR   KEGG; hsa:23067; -.
DR   UCSC; uc021rfg.2; human. [Q9UPS6-1]
DR   CTD; 23067; -.
DR   DisGeNET; 23067; -.
DR   GeneCards; SETD1B; -.
DR   H-InvDB; HIX0011090; -.
DR   HGNC; HGNC:29187; SETD1B.
DR   HPA; HPA021667; -.
DR   HPA; HPA059412; -.
DR   MIM; 611055; gene.
DR   neXtProt; NX_Q9UPS6; -.
DR   OpenTargets; ENSG00000139718; -.
DR   PharmGKB; PA143485611; -.
DR   eggNOG; KOG1080; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00760000119228; -.
DR   HOGENOM; HOG000168216; -.
DR   HOVERGEN; HBG055596; -.
DR   InParanoid; Q9UPS6; -.
DR   KO; K11422; -.
DR   OMA; TSADCPK; -.
DR   OrthoDB; EOG091G00IV; -.
DR   TreeFam; TF106436; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   GenomeRNAi; 23067; -.
DR   PRO; PR:Q9UPS6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139718; -.
DR   CleanEx; HS_SETD1B; -.
DR   ExpressionAtlas; Q9UPS6; baseline and differential.
DR   Genevisible; Q9UPS6; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035097; C:histone methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; IDA:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd12549; RRM_Set1B; 1.
DR   InterPro; IPR024657; COMPASS_Set1_N-SET.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034468; Set1B_RRM.
DR   InterPro; IPR001214; SET_dom.
DR   Pfam; PF11764; N-SET; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01291; N-SET; 1.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Chromosome; Coiled coil; Complete proteome; Methyltransferase;
KW   Nucleus; Phosphoprotein; Reference proteome; RNA-binding;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase.
FT   CHAIN         1   1966       Histone-lysine N-methyltransferase
FT                                SETD1B.
FT                                /FTId=PRO_0000316993.
FT   DOMAIN       93    181       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN     1827   1944       SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00190}.
FT   DOMAIN     1950   1966       Post-SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00155}.
FT   COILED     1173   1204       {ECO:0000255}.
FT   COMPBIAS    366   1671       Pro-rich.
FT   COMPBIAS   1040   1175       Ser-rich.
FT   COMPBIAS   1068   1312       Glu-rich.
FT   COMPBIAS   1103   1138       Asp-rich.
FT   BINDING    1943   1943       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00190}.
FT   MOD_RES     986    986       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     994    994       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1031   1031       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1265   1265       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   MOD_RES    1283   1283       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   MOD_RES    1335   1335       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1659   1659       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1663   1663       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   VAR_SEQ    1043   1068       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053875.
FT   VAR_SEQ    1088   1104       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053876.
FT   MUTAGEN     577    577       L->A: Abolishes interaction with RBM15.
FT                                {ECO:0000269|PubMed:22927943}.
FT   MUTAGEN     579    579       D->A: Abolishes interaction with RBM15.
FT                                {ECO:0000269|PubMed:22927943}.
FT   HELIX      1747   1750       {ECO:0000244|PDB:4ES0}.
SQ   SEQUENCE   1966 AA;  212803 MW;  164F81BC84EAD2C2 CRC64;
     MENSHPPHHH HQQPPPQPGP SGERRNHHWR SYKLMIDPAL KKGHHKLYRY DGQHFSLAMS
     SNRPVEIVED PRVVGIWTKN KELELSVPKF KIDEFYVGPV PPKQVTFAKL NDNIRENFLR
     DMCKKYGEVE EVEILYNPKT KKHLGIAKVV FATVRGAKDA VQHLHSTSVM GNIIHVELDT
     KGETRMRFYE LLVTGRYTPQ TLPVGELDAV SPIVNETLQL SDALKRLKDG GLSAGCGSGS
     SSVTPNSGGT PFSQDTAYSS CRLDTPNSYG QGTPLTPRLG TPFSQDSSYS SRQPTPSYLF
     SQDPAVTFKA RRHESKFTDA YNRRHEHHYV HNSPAVTAVA GATAAFRGSS DLPFGAVGGT
     GGSSGPPFKA QPQDSATFAH TPPPAQATPA PGFKSAFSPY QTPVAHFPPP PEEPTATAAF
     GARDSGEFRR APAPPPLPPA EPLAKEKPGT PPGPPPPDTN SMELGGRPTF GWSPEPCDSP
     GTPTLESSPA GPEKPHDSLD SRIEMLLKEQ RTKLLFLREP DSDTELQMEG SPISSSSSQL
     SPLAPFGTNS QPGFRGPTPP SSRPSSTGLE DISPTPLPDS DEDEELDLGL GPRPPPEPGP
     PDPAGLLSQT AEVALDLVGD RTPTSEKMDE GQQSSGEDME ISDDEMPSAP ITSADCPKPM
     VVTPGAAAVA APSVLAPTLP LPPPPGFPPL PPPPPPPPPQ PGFPMPPPLP PPPPPPPPAH
     PAVTVPPPPL PAPPGVPPPP ILPPLPPFPP GLFPVMQVDM SHVLGGQWGG MPMSFQMQTQ
     VLSRLMTGQG ACPYPPFMAA AAAAASAGLQ FVNLPPYRGP FSLSNSGPGR GQHWPPLPKF
     DPSVPPPGYM PRQEDPHKAT VDGVLLVVLK ELKAIMKRDL NRKMVEVVAF RAFDEWWDKK
     ERMAKASLTP VKSGEHKDED RPKPKDRIAS CLLESWGKGE GLGYEGLGLG IGLRGAIRLP
     SFKVKRKEPP DTTSSGDQKR LRPSTSVDEE DEESERERDR DMADTPCELA KRDPKGVGVR
     RRPARPLELD SGGEEDEKES LSASSSSSAS SSSGSSTTSP SSSASDKEEE QESTEEEEEA
     EEEEEEEVPR SQLSSSSTSS TSDKDDDDDD SDDRDESEND DEDTALSEAS EKDEGDSDEE
     ETVSIVTSKA EATSSSESSE SSEFESSSES SPSSSEDEEE VVAREEEEEE EEEEMVAEES
     MASAGPEDFE QDGEEAALAP GAPAVDSLGM EEEVDIETEA VAPEERPSML DEPPLPVGVE
     EPADSREPPE EPGLSQEGAM LLSPEPPAKE VEARPPLSPE RAPEHDLEVE PEPPMMLPLP
     LQPPLPPPRP PRPPSPPPEP ETTDASHPSV PPEPLAEDHP PHTPGLCGSL AKSQSTETVP
     ATPGGEPPLS GGSSGLSLSS PQVPGSPFSY PAPSPSLSSG GLPRTPGRDF SFTPTFSEPS
     GPLLLPVCPL PTGRRDERSG PLASPVLLET GLPLPLPLPL PLPLALPAVL RAQARAPTPL
     PPLLPAPLAS CPPPMKRKPG RPRRSPPSML SLDGPLVRPP AGAALGRELL LLPGQPQTPV
     FPSTHDPRTV TLDFRNAGIP APPPPLPPQP PPPPPPPPVE PTKLPFKELD NQWPSEAIPP
     GPRGRDEVTE EYMELAKSRG PWRRPPKKRH EDLVPPAGSP ELSPPQPLFR PRSEFEEMTI
     LYDIWNGGID EEDIRFLCVT YERLLQQDNG MDWLNDTLWV YHPSTSLSSA KKKKRDDGIR
     EHVTGCARSE GFYTIDKKDK LRYLNSSRAS TDEPPADTQG MSIPAQPHAS TRAGSERRSE
     QRRLLSSFTG SCDSDLLKFN QLKFRKKKLK FCKSHIHDWG LFAMEPIAAD EMVIEYVGQN
     IRQVIADMRE KRYEDEGIGS SYMFRVDHDT IIDATKCGNF ARFINHSCNP NCYAKVITVE
     SQKKIVIYSK QHINVNEEIT YDYKFPIEDV KIPCLCGSEN CRGTLN
//
